Dementia and Sleep: Changes, Causes, and Safer Care

Dementia and sleep can affect each other, but the relationship is not simple. Alzheimer disease and other brain diseases can disrupt the systems that organize sleep, alertness, and the 24-hour body clock. Poor sleep can then worsen attention, memory performance, mood, balance, and behavior the next day.

A sleep problem does not prove that someone has dementia, and dementia should not be blamed for every difficult night. Pain, nocturia, constipation, depression, infection, medication effects, obstructive sleep apnea, restless legs syndrome, and other treatable problems can look like dementia-related sleep disruption. Treating them may improve comfort, function, and safety. It has not been shown to reverse dementia.

Research also links several sleep problems with a higher rate of later cognitive decline or dementia. These are mainly observational associations. They do not show that a particular person's insomnia or short sleep directly caused dementia, or that improving sleep will prevent it.

What a two-way relationship means

Dementia can alter sleep in several ways. Degeneration may affect brain networks involved in circadian timing, arousal, movement, and behavior. Reduced daylight, lower activity, irregular meals, unfamiliar environments, and more daytime dozing can further weaken the contrast between day and night.

Sleep disruption can also make existing cognitive symptoms more visible. A person may be less attentive, more irritable, slower to respond, or more unsteady after a poor night. That temporary worsening is not necessarily evidence that the underlying dementia advanced overnight.

The third part of the relationship is still being studied. Longitudinal studies associate insomnia, fragmented sleep, sleep-disordered breathing, excessive daytime sleepiness, and very short or long reported sleep with later cognitive decline. The results vary by how sleep and cognition were measured, the population studied, and how long people were followed ¹.

There are at least three possible explanations:

• a sleep disorder may contribute to vascular, inflammatory, metabolic, or brain changes
• early neurodegeneration may disturb sleep years before dementia is diagnosed
• a third factor, such as depression, cardiovascular disease, medication, inactivity, or frailty, may affect both sleep and cognition

More than one explanation can be true. This is why sleep deserves assessment without being marketed as a proven dementia-prevention treatment.

What mechanism studies can tell us

Laboratory findings offer possible explanations, but they are not clinical proof. In a mouse study, sleep was associated with greater movement of fluid through brain tissue and faster clearance of metabolites, including amyloid-beta ². Animal findings cannot establish how much this process affects dementia risk in people.

A PET study of 20 healthy adults found a higher beta-amyloid signal in two brain regions after one night of total sleep deprivation ³. This was a small, short-term biomarker study, not a study of dementia onset. Together, these findings make biological pathways plausible. They do not show that ordinary poor sleep causes dementia or that a sleep treatment prevents it.

Sleep patterns differ across cognitive diagnoses

Dementia is a syndrome, not one disease. Mixed pathology is also common, so a sleep symptom cannot determine the subtype by itself.

Diagnosis or stage	Sleep features that may matter	Main boundary
Alzheimer disease	Fragmented nighttime sleep, daytime dozing, circadian disorganization, and late-day agitation may occur	These changes are variable and not diagnostic. See the focused Alzheimer’s disease and sleep guide for detailed caregiving steps
Dementia with Lewy bodies	REM sleep behavior disorder, excessive daytime sleepiness, insomnia, and other sleep disorders can be prominent	Dream enactment is a core diagnostic clue but still needs clinical assessment, often including a sleep study 45
Vascular dementia	Sleep apnea, stroke effects, pain, mood symptoms, and vascular conditions may all disrupt sleep	There is no single vascular-dementia sleep pattern. New weakness, facial droop, speech trouble, or loss of balance is an emergency, not a sleep problem
Frontotemporal dementia	Changes in sleep duration, sleep quality, and rest-activity timing have been reported, especially in behavioral-variant disease	Research is limited and does not support using a sleep pattern to diagnose frontotemporal dementia 6
Mild cognitive impairment	Sleep apnea, depression, medicines, and sleep disruption can worsen cognitive performance	Mild cognitive impairment is not dementia. It can remain stable, improve, or progress, so both sleep contributors and cognition need follow-up 7

Alzheimer disease and circadian disruption

A person with Alzheimer disease may wake repeatedly, remain awake at night, sleep more during the day, or become restless in the late afternoon or evening. “Sundowning” describes a recurring late-day pattern of confusion, agitation, or restlessness. It is not a separate diagnosis and should not be used to explain a sudden change.

Lewy body dementia and dream enactment

REM sleep behavior disorder occurs when the normal muscle quieting of REM sleep is lost and a person moves or speaks in response to a dream. Shouting, punching, kicking, grabbing, or falling from bed may occur. Other parasomnias, severe sleep apnea, seizures, and medication effects can resemble it.

REM sleep behavior disorder is strongly associated with Lewy body diseases and can precede cognitive or movement symptoms, but it does not establish a dementia diagnosis by itself ⁴. New dream enactment needs a sleep or neurology assessment. Until then, remove weapons and sharp or breakable objects, pad nearby furniture, lower the sleep surface if this can be done safely, and protect the bed partner. The American Academy of Sleep Medicine places injury prevention at the center of REM sleep behavior disorder care ⁸.

Vascular and frontotemporal dementia

Vascular brain injury can affect sleep and alertness, but sleepiness or insomnia does not identify vascular dementia. Sleep apnea and vascular risk often coexist, and both deserve ordinary evidence-based care. A sudden neurologic change may signal a new stroke and requires emergency assessment.

Sleep and circadian research in frontotemporal dementia is much smaller than in Alzheimer disease. A study of 27 people with behavioral-variant frontotemporal dementia found longer sleep, lower sleep efficiency, and altered morning and early-afternoon activity compared with controls. It was a small observational study, so the findings describe a group pattern rather than a diagnostic test or rule for an individual ⁶.

Identify the sleep problem before treating it

“Not sleeping” can refer to very different patterns. Describe what is actually happening, when it happens, and how it affects the person and caregiver.

Insomnia or a shifted body clock

Insomnia involves difficulty falling asleep, staying asleep, or returning to sleep despite a reasonable opportunity to sleep, with a daytime effect. Circadian disruption is different. The person may sleep at an unintended time, nap across the day and night, or have no consolidated main sleep period.

A person who goes to bed very early and wakes before dawn may not have the same problem as someone who is awake and distressed for hours overnight. Likewise, lying in bed is not proof of sleep. A caregiver's record of sleep, waking, bathroom trips, calls, pacing, and naps can be more informative than total time in bed.

Daytime sleepiness and napping

More napping can reflect a fragmented night, sleep apnea, sedating medicine, depression, low activity, illness, or progression of a neurologic disorder. Sudden unusual sleepiness is a medical change, not a routine nap issue.

Naps do not need to be banned. If long or late naps consistently delay nighttime sleep, moving rest earlier or shortening it gradually may help. In later dementia, acute illness, or substantial fatigue, needed daytime rest should be individualized rather than withheld to force sleep.

Obstructive sleep apnea

Loud habitual snoring, repeated breathing pauses, gasping, morning headaches, dry mouth, and marked daytime sleepiness can suggest obstructive sleep apnea (OSA). None of these symptoms, alone, confirms it. A home or laboratory sleep study may be needed.

OSA should be treated for its established effects on breathing, sleepiness, and sleep-related quality of life, not as a promised dementia treatment ⁹. Positive airway pressure may require caregiver help with the mask, setup, cleaning, and consistent use.

Evidence for cognitive benefit in established dementia remains limited. In a randomized study of 52 people with mild to moderate Alzheimer disease and OSA, three weeks of therapeutic CPAP did not significantly outperform placebo CPAP on the overall cognitive comparison. Exploratory analyses after therapeutic treatment suggested possible improvements in some tests, but the study was underpowered for firm conclusions ¹⁰. CPAP treats OSA; current evidence does not show that it prevents or reverses dementia.

Restless legs and periodic limb movements

Restless legs syndrome causes an urge to move the legs, often with unpleasant sensations that worsen during rest and in the evening and improve with movement. Periodic limb movements are repeated movements during sleep and may occur with or without restless legs symptoms.

Dementia can make the internal urge hard to describe. Repeated rubbing, getting up, kicking, or a bed partner's report of rhythmic movements may justify assessment, but pain, cramps, arthritis, medication-related restlessness, and other conditions can look similar. Current AASM guidance emphasizes checking iron status and reviewing contributors such as certain antihistaminergic, serotonergic, or antidopaminergic medicines and untreated OSA before selecting RLS treatment ¹¹. Do not start iron or change a neurologic medicine without appropriate testing and clinical guidance.

Check for treatable contributors

A new sleep or nighttime behavior problem deserves a clinical and environmental review. NICE recommends looking for causes of distress such as pain, delirium, inappropriate care, and environmental factors before adding a non-drug or drug treatment ¹².

Common contributors include:

• pain, reflux, constipation, hunger, thirst, or an uncomfortable room
• urinary urgency, nocturia, infection, or difficulty finding the bathroom
• shortness of breath, cough, itching, fever, or another illness
• depression, anxiety, grief, loneliness, or frightening hallucinations
• too little daylight, activity, or social contact during the day
• caffeine, alcohol, nicotine, or substance withdrawal
• a new medicine, dose, timing change, missed dose, interaction, or withdrawal effect
• poor vision or hearing that increases nighttime disorientation
• an unfamiliar hospital, care setting, room, or caregiver routine

Pain may appear as grimacing, guarding, moaning, repeated repositioning, resisting care, or unexplained agitation when a person cannot describe it. Nocturia can be both a medical issue and a fall risk. The safer response is to identify the need and make the route to the toilet safer, not simply sedate the person.

When a sleep change may be delirium

Dementia usually changes gradually. Delirium develops over hours or days and often fluctuates. It can appear as new confusion, agitation, hallucinations, reversed sleep, reduced movement, withdrawal, slow responses, or unusual drowsiness.

People with dementia are at higher risk of delirium. Infection, dehydration, pain, constipation, urinary retention, medication effects, metabolic problems, and recent surgery or hospitalization are possible triggers. NICE advises assessing recent changes in cognition, perception, physical function, sleep, and social behavior, and managing delirium first when it is difficult to distinguish from dementia ¹³.

Contact a medical professional promptly whenever the person is suddenly different from baseline. A quiet, sleepy form of delirium can be missed as easily as an agitated form.

What an assessment may include

Start with the person whenever possible and include someone who knows their usual behavior. The Alzheimer’s Association diagnostic guideline emphasizes history from both the patient and a care partner, functional assessment, cognitive testing, examination, and evaluation of other conditions or factors such as mood, sleep apnea, medicines, and alcohol that may contribute to cognitive or behavioral symptoms ⁷.

A practical sleep assessment may include:

1. A pattern record. For several representative days, note bedtime, estimated sleep, waking, naps, bathroom trips, breathing symptoms, movements, dream enactment, distress, falls, and medicine timing.
2. A baseline comparison. Record what changed, when it began, whether it fluctuates, and what the person could usually do before the change.
3. A medical and medication review. Include prescriptions, over-the-counter products, supplements, caffeine, alcohol, pain, mood, urinary and bowel symptoms, and recent illness or changes in care.
4. Targeted testing. Depending on the pattern, this may include blood or urine tests, iron studies, a sleep study, or specialist assessment. A laboratory sleep study is particularly useful when dream enactment, unusual movements, seizures, or complex breathing disorders are in question.
5. A shared goal. Decide whether the priority is less distress, safer nighttime mobility, more consolidated sleep, better daytime alertness, treatment of a diagnosed disorder, or relief for an exhausted caregiver.

A consumer tracker may show a change in movement or routine, but it cannot diagnose dementia, delirium, OSA, REM sleep behavior disorder, or periodic limb movement disorder.

Start with a personalized daytime and nighttime plan

NICE recommends a personalized, multicomponent approach that can include sleep education, daylight, exercise, and meaningful activities ¹². This is a reasonable framework, but expectations should be modest. A 2023 Cochrane review found low or very-low certainty evidence and could not identify one reliably effective non-drug sleep intervention for everyone with dementia ¹⁴.

Strengthen daytime cues

• Keep the waking time, meals, personal care, and major activities reasonably consistent.
• Offer daylight and safe activity earlier in the day, matched to mobility, health, and preferences.
• Use hearing aids and glasses when needed so daytime cues and social contact remain clear.
• Plan meaningful activity without exhausting or overstimulating the person.
• If late naps are shifting sleep, adjust them gradually rather than imposing sleep deprivation.

Ordinary daylight and activity are useful time cues even though formal light-box treatment has uncertain evidence. Light therapy studies vary in brightness, timing, duration, setting, dementia stage, and outcome. The Cochrane review found no clear sleep benefit from light therapy alone ¹⁴. A timed bright-light device should therefore be treated as a planned intervention, not a universally effective bedroom product.

Make the evening easier to interpret

• Move demanding appointments and personal care to the person's better time of day when possible.
• Reduce confusing shadows, glare, noise, clutter, and competing conversations.
• Use familiar, calm activities instead of arguing about the time or forcing sleep.
• Check pain, temperature, hunger, thirst, constipation, clothing, bedding, and toileting before bed.
• Keep the route to the bathroom visible and clear without making the whole home brightly stimulating.
• If the person wakes, respond to the immediate need and redirect calmly rather than repeatedly insisting that it is nighttime.

A routine is an anchor, not a test the person or caregiver can fail. Adapt it as abilities, health, and the care setting change.

Nighttime wandering and injury prevention

Wandering may reflect disorientation, a search for the bathroom, pain, restlessness, an old routine, fear, or a wish to “go home.” No safety measure can guarantee that it will not happen.

Consider:

• clearing walking routes and removing loose rugs and trip hazards
• using low, even lighting on the route to the bathroom
• securing medicines, weapons, vehicle keys, and hazardous tools
• using a door or movement alert that does not frighten the person
• keeping current identification and a recent photo available
• telling trusted neighbors or facility staff about the plan
• arranging supervision when the person cannot navigate safely alone

Do not use a restraint or create a lock arrangement that blocks emergency escape. Review the plan as behavior and mobility change. The Alzheimer’s Association recommends planning search steps in advance and beginning a search immediately when a person with dementia is missing ¹⁵. Contact local emergency services promptly, especially when weather, traffic, water, injury, missing medication, or another immediate danger is involved.

Melatonin, light, and sleep medicines

Melatonin is not one treatment for every pattern

Melatonin is often proposed because dementia can affect circadian timing. Trials have not shown a reliable general benefit for insomnia in Alzheimer disease. NICE specifically advises against offering melatonin to manage insomnia in people with Alzheimer disease, and a Cochrane review found little or no effect on major sleep outcomes in the available Alzheimer trials ¹²¹⁶.

REM sleep behavior disorder is a different indication. The AASM conditionally recommends immediate-release melatonin for some adults with isolated or secondary REM sleep behavior disorder, alongside bedroom safety, but evidence and product consistency are limited ⁸. A clinician should separate the target condition, formulation, interactions, and daytime-sedation risk rather than treating all dementia-related sleep problems with the same supplement.

Sedating and anticholinergic medicines can add risk

Diphenhydramine, doxylamine, and other strongly anticholinergic drugs are found in some over-the-counter sleep and “nighttime” combination products. Anticholinergic effects can add confusion, dry mouth, constipation, urinary retention, and blurred vision. The cumulative burden can come from several prescriptions and nonprescription products. NICE recommends minimizing medicines with anticholinergic burden when possible during dementia care and medication review ¹².

Benzodiazepines and “Z-drug” hypnotics can increase cognitive impairment, delirium, falls, fractures, and next-day impairment in older adults. The American Geriatrics Society Beers Criteria advises avoiding these drugs in many older adults and highlights additional concern in dementia, delirium, and fall risk ¹⁷.

Antipsychotics should not be used simply to make a person sleep. NICE limits their use in dementia to situations involving risk of harm or severe distress from agitation, hallucinations, or delusions, with particular concern for severe sensitivity reactions in dementia with Lewy bodies ¹².

This does not mean that no prescription can ever be appropriate. Small trials have found possible short-term sleep benefits from some medicines in selected people with Alzheimer disease, but the evidence is sparse and does not establish one safe default for all dementias ¹⁶. Any prescription should have:

• a clearly named target symptom or disorder
• a review of falls, breathing, cognition, interactions, and daytime function
• a plan to measure benefit
• a date to reassess, reduce, or stop it if benefit is not meaningful

Do not stop a benzodiazepine, antidepressant, antipsychotic, or other long-term medicine suddenly without prescriber guidance. Withdrawal can cause severe sleep and health problems.

Include the caregiver in the sleep plan

Nighttime supervision can leave a caregiver too sleep-deprived to drive, manage medicines, respond calmly, or remain healthy. The caregiver's sleep is therefore a safety issue, not an optional comfort.

Share overnight responsibility when possible. Ask the dementia care coordinator, primary-care team, social worker, family, home-care service, or respite program what support is available. NICE recommends tailored education and skills support for carers, attention to their physical and mental health, and assessment for respite and other support ¹².

Say plainly when one person can no longer provide safe nighttime supervision. A care plan may need more in-home help, planned respite, a different sleep arrangement, or a higher level of care.

When to seek help

Arrange a clinical review for a persistent change in sleep timing, repeated insomnia, marked daytime sleepiness, snoring or breathing pauses, dream enactment, leg symptoms, nighttime falls, worsening mood, medication concerns, or wandering. Bring the pattern record and a complete list of medicines and supplements.

Seek prompt medical assessment for:

• confusion, withdrawal, agitation, hallucinations, or unusual drowsiness that developed over hours or days
• fever, new urinary or respiratory symptoms, dehydration, severe constipation, urinary retention, or significant pain with a mental change
• a new fall, head injury, or injury during wandering or dream enactment
• rapidly worsening cognition or function
• caregiver exhaustion that makes overnight care unsafe

Call emergency services for stroke signs, chest pain, severe breathing difficulty, blue or gray lips or skin, a seizure, inability to wake the person normally, a serious injury, immediate danger from behavior, or a missing person at significant risk. Sudden confusion or behavior change should never be assumed to be normal dementia progression.